These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1077 related articles for article (PubMed ID: 26199650)
1. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer. Bertoli G; Cava C; Castiglioni I Theranostics; 2015; 5(10):1122-43. PubMed ID: 26199650 [TBL] [Abstract][Full Text] [Related]
2. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer. Bertoli G; Cava C; Castiglioni I Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502 [TBL] [Abstract][Full Text] [Related]
3. The role of miRNAs as biomarkers in breast cancer. Baylie T; Kasaw M; Getinet M; Getie G; Jemal M; Nigatu A; Ahmed H; Bogale M Front Oncol; 2024; 14():1374821. PubMed ID: 38812786 [TBL] [Abstract][Full Text] [Related]
4. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression. Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789 [TBL] [Abstract][Full Text] [Related]
5. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer. Dwedar FI; Shams-Eldin RS; Nayer Mohamed S; Mohammed AF; Gomaa SH J Clin Lab Anal; 2021 Aug; 35(8):e23887. PubMed ID: 34264524 [TBL] [Abstract][Full Text] [Related]
6. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer. Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174 [TBL] [Abstract][Full Text] [Related]
7. Bioinformatic Analysis Divulged Novel Prognostic Circulating MicroRNAs and Their Potential Target Genes in Breast Cancer. Pourgholamali B; Sohrabi B; Salbi M; Akbari S; Rastan I; Sayaf M; Jalil AT; Kadhim MM; Sheervalilou R; Mehrzad N Appl Biochem Biotechnol; 2023 Jan; 195(1):283-297. PubMed ID: 36074234 [TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer. Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524 [TBL] [Abstract][Full Text] [Related]
9. Identification of a six-microRNA signature as a potential diagnostic biomarker in breast cancer tissues. Mahmoudian M; Razmara E; Mahmud Hussen B; Simiyari M; Lotfizadeh N; Motaghed H; Khazraei Monfared A; Montazeri M; Babashah S J Clin Lab Anal; 2021 Nov; 35(11):e24010. PubMed ID: 34528314 [TBL] [Abstract][Full Text] [Related]
10. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases. Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475 [TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer. Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526 [TBL] [Abstract][Full Text] [Related]
12. Candidate miRNAs in human breast cancer biomarkers: a systematic review. Adhami M; Haghdoost AA; Sadeghi B; Malekpour Afshar R Breast Cancer; 2018 Mar; 25(2):198-205. PubMed ID: 29101635 [TBL] [Abstract][Full Text] [Related]
13. The diagnostic significance of circulating miRNAs and metabolite profiling in early prediction of breast cancer in Egyptian women. El-Toukhy SE; El-Daly SM; Kamel MM; Nabih HK J Cancer Res Clin Oncol; 2023 Jul; 149(8):5437-5451. PubMed ID: 36459290 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential. Asiaf A; Ahmad ST; Arjumand W; Zargar MA Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366 [TBL] [Abstract][Full Text] [Related]
15. A comprehensive review on oncogenic miRNAs in breast cancer. Maryam M; Naemi M; Hasani SS J Genet; 2021; 100():. PubMed ID: 33764337 [TBL] [Abstract][Full Text] [Related]
16. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. Hafez MM; Hassan ZK; Zekri AR; Gaber AA; Al Rejaie SS; Sayed-Ahmed MM; Al Shabanah O Asian Pac J Cancer Prev; 2012; 13(2):591-8. PubMed ID: 22524830 [TBL] [Abstract][Full Text] [Related]
17. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis. Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533 [TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Response to Therapy: Can microRNAs Lead the Way? Petrović N; Nakashidze I; Nedeljković M J Mammary Gland Biol Neoplasia; 2021 Jun; 26(2):157-178. PubMed ID: 33479880 [TBL] [Abstract][Full Text] [Related]
19. Value of miR-31 and miR-150-3p as diagnostic and prognostic biomarkers for breast cancer. Erturk E; Ari F; Onur OE; Mustafa Gokgoz S; Tolunay S Mol Biol Rep; 2024 Oct; 51(1):1030. PubMed ID: 39352561 [TBL] [Abstract][Full Text] [Related]
20. miRNAs as radio-response biomarkers for breast cancer stem cells. Griñán-Lisón C; Olivares-Urbano MA; Jiménez G; López-Ruiz E; Del Val C; Morata-Tarifa C; Entrena JM; González-Ramírez AR; Boulaiz H; Zurita Herrera M; Núñez MI; Marchal JA Mol Oncol; 2020 Mar; 14(3):556-570. PubMed ID: 31930680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]